Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea on exertion major surgical or invasive procedure: aortic valve replacment (21mm mosaic), septal myomectomy history of present illness: mrs. is a 76 y/o female with a significant pmh for coronary artery disease s/p stenting, aortic stenosis and hypertrophic cardiomyopathy who was admitted for heart failure management prior to elective valve surgery. past medical history: aortic stenosis and hypertrophic cardiomyopathy, coronary artery disease s/p lad bare metal stenting , congestive heart failure, hypertension, hypercholesterolemia, diabetes mellitus, right breast cancer s/p mastectomy and chemotherapy, obesity, pneumonia , s/p appendectomy, s/p cholecystectomy, s/p ventral hernia repair, anemia social history: widowed and lives alone. she has 3 children, one working as nurse. . family history: father died of mi at age 65 physical exam: at discharge: vs: t97 130/60 p81 18 gen: no acute distress neck: full range of motion, -vein distention chest: lungs clear heart: regular rate and rhythm, -murmur abd: soft, non-tender, non-distended, +bowel sounds ext: warm, 1+edema neuro: alert and oriented x 3, non-focal pertinent results: echo: the left atrium is markedly dilated. no mass/thrombus is seen in the left atrium or left atrial appendage. there is mild symmetric left ventricular hypertrophy. overall left ventricular systolic function is mildly depressed (lvef= 55%there is no ventricular septal defect. there are complex (>4mm) atheroma in the ascending aorta. the aortic valve leaflets are severely thickened/deformed. there is severe aortic valve stenosis (area <0.8cm2). trace aortic regurgitation is seen. the mitral valve leaflets are severely thickened/deformed. there is moderate valvular mitral stenosis (area 1.0-1.5cm2). .there is severe mitral annular calcification.moderate (1+) mitral regurgitation is seen. post bypass: patient is on a neo drip @1 mcg/kg/min. there is now a well seated 21 bioprosthetic valve in place. there is a mean gradient of 15 across the aortic valve. there is no ai. the mitral stenosis valve area is still 1.2-1.3cm2. ventricular function is preserved at 55%. there is mild chordal . 06:15am blood wbc-5.8 rbc-3.46* hgb-9.8* hct-28.1* mcv-81* mch-28.4 mchc-34.8 rdw-15.4 plt ct-239 07:17pm blood wbc-8.5 rbc-3.72* hgb-10.9* hct-31.2* mcv-84 mch-29.3 mchc-34.9 rdw-15.8* plt ct-257 06:15am blood pt-13.7* ptt-24.3 inr(pt)-1.2* 04:29am blood pt-13.5* ptt-26.0 inr(pt)-1.2* 06:15am blood glucose-121* urean-29* creat-1.0 na-138 k-4.7 cl-102 hco3-26 angap-15 07:17pm blood glucose-149* urean-41* creat-1.0 na-133 k-4.0 cl-98 hco3-27 angap-12 06:08am blood calcium-8.8 phos-3.6 mg-1.9 brief hospital course: as mentioned in the hpi, mrs. was admitted for management prior to undergoing valve surgery. she had pre-operative work-up and was medically optimized for surgery. on she was brought to the operating room where she underwent an aortic valve replacement and septal myomectomy. please see operative report for surgical details. following surgery she was transferred to the cvicu for invasive monitoring in stable condition. within 24 hours she was weaned from sedation, awoke neurologically intact and extubated. beta blockers and diuretics were started and she was titrated towards her pre-op weight. on post-op day two chest tubes were removed. epicardial pacing wires were removed on post-op day three. several anti-hypertensive medication were added to regime for maximum bp control. on post-op day four she was transferred to the telemetry floor for further care. on post-op day five she appeared to be doing well and was discharged home with vna services and the appropriate follow-up appointments. medications on admission: metformin 1000mg , plavix 75mg qd, aspirin 325mg qd, lisinopril 40mg qd, hctz 25mg qd, prilosec 20mg qd, iron 325mg qd, mvi qd, fish oil 1000mg qd, vitamin d qd, toprol xl 75mg qd, simvastatin 80mg qd, amlodipine 5mg qd, darvon prn discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*1* 4. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*40 tablet(s)* refills:*0* 5. metformin 500 mg tablet sig: two (2) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*1* 6. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*1* 7. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*1* 8. metoprolol tartrate 50 mg tablet sig: 1.5 tablets po tid (3 times a day). disp:*135 tablet(s)* refills:*1* 9. albuterol 90 mcg/actuation aerosol sig: two (2) puff inhalation q6h (every 6 hours). disp:*1 * refills:*1* 10. ipratropium bromide 17 mcg/actuation aerosol sig: two (2) puff inhalation q6h (every 6 hours). disp:*1 * refills:*1* 11. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*1* 12. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po q12h (every 12 hours) for 10 days. disp:*20 tab sust.rel. particle/crystal(s)* refills:*0* 13. furosemide 20 mg tablet sig: one (1) tablet po twice a day for 10 days. disp:*20 tablet(s)* refills:*0* discharge disposition: home with service facility: moultonboro vna discharge diagnosis: aortic stenosis and hypertrophic cardiomyopathy s/p aortic valve replacement and septal myomectomy congestive heart failure pmh: stroke, coronary artery disease s/p lad bare metal stenting , hypertension, hypercholesterolemia, diabetes mellitus, right breast cancer s/p mastectomy and chemotherapy, obesity, pneumonia , s/p appendectomy, s/p cholecystectomy, s/p ventral hernia repair, anemia discharge condition: good discharge instructions: no driving for 4 weeks. no lifting more than 10 pounds for 10 weeks. shower daily, no baths. report any temperature greater than 100.5. report any weight gain greater than 2 pounds a day or 5 pounds a week. report any redness of, or drainage from incisions. no lotions, creams or powders to incisions. followup instructions: dr. in 4 weeks dr. in weeks dr. in weeks procedure: venous catheterization, not elsewhere classified extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart excision or destruction of other lesion or tissue of heart, open approach open and other replacement of aortic valve with tissue graft diagnoses: anemia, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia mitral valve disorders congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortic valve disorders personal history of malignant neoplasm of breast percutaneous transluminal coronary angioplasty status personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obesity, unspecified diastolic heart failure, unspecified personal history of antineoplastic chemotherapy history of fall 

Answer: The patient is high likely exposed to